Nakagawa K, Ouchi K, Matsubara S, Hashimoto L, Yajima Y
First Department of Surgery, Tohoku University School of Medicine, Sendai.
Tohoku J Exp Med. 1987 Oct;153(2):133-6. doi: 10.1620/tjem.153.133.
In order to prevent endotoxemia after hepatectomy in cirrhotic patients, we administered OK-432 before and after hepatectomy to activate the reticuloendothelial function and studied its effect on postoperative endotoxemia. In the cirrhotic group without OK-432 administration (7 patients), the value of endotoxin increased significantly after hepatectomy, compared to the cirrhotic group which received OK-432 administration (5 patients) and the non-cirrhotic group (12 patients), and the endotoxin level was still higher than the preoperative value even on the 14th day. On the other hand, the cirrhotic group with OK-432 administration and the non-cirrhotic group showed minimal increases of endotoxin levels at the first day, which returned to the preoperative values at the third day. Base on these findings, it is suggested that activation of the reticuloendothelial function bears substantial significance as one of the therapeutic modalities for prevention of endotoxemia after hepatectomy in cirrhotic patients.
为预防肝硬化患者肝切除术后发生内毒素血症,我们在肝切除术前及术后给予OK-432以激活网状内皮系统功能,并研究其对术后内毒素血症的影响。在未给予OK-432的肝硬化组(7例患者)中,与接受OK-432治疗的肝硬化组(5例患者)及非肝硬化组(12例患者)相比,肝切除术后内毒素值显著升高,甚至在第14天其内毒素水平仍高于术前值。另一方面,给予OK-432的肝硬化组和非肝硬化组在术后第1天内毒素水平仅有轻微升高,并在第3天恢复至术前值。基于这些发现,提示激活网状内皮系统功能作为预防肝硬化患者肝切除术后内毒素血症的治疗方式之一具有重要意义。